The receptor is an ionotropic receptor and ligand-gated ion channel. Its endogenous ligand is γ-aminobutyric acid (GABA), the major inhibitory neurotransmitter in the central nervous system. Upon activation, the GABAA receptor selectively conducts Cl- through its pore, resulting in hyperpolarization of the neuron. This causes an inhibitory effect on neurotransmission by diminishing the chance of a successful action potential occurring.
The active site of the GABAA receptor is the binding site for GABA and several drugs such as muscimol, gaboxadol, and bicuculline. The protein also contains a number of different allosteric binding sites which modulate the activity of the receptor indirectly.
Organism species: Homo sapiens (Human)
CATALOG NO. | PRODUCT NAME | APPLICATIONS | |
Proteins | CPD086Hu11 | BSA Conjugated Gamma-Aminobutyric Acid A Receptor Alpha 1 (gABRa1) | Immunogen; SDS-PAGE; WB. |
CPD086Hu21 | OVA Conjugated Gamma-Aminobutyric Acid A Receptor Alpha 1 (gABRa1) | Immunogen; SDS-PAGE; WB. | |
RPD086Hu01 | Recombinant Gamma-Aminobutyric Acid A Receptor Alpha 1 (gABRa1) | Positive Control; Immunogen; SDS-PAGE; WB. | |
Antibodies | PAD086Hu08 | Polyclonal Antibody to Gamma-Aminobutyric Acid A Receptor Alpha 1 (gABRa1) | WB; IHC; ICC; IP. |
MAD086Hu21 | Monoclonal Antibody to Gamma-Aminobutyric Acid A Receptor Alpha 1 (gABRa1) | WB; IHC; ICC; IP. | |
Assay Kits | n/a | CLIA Kit for Gamma-Aminobutyric Acid A Receptor Alpha 1 (gABRa1) | CLIA Kit Customized Service Offer |
n/a | ELISA Kit for Gamma-Aminobutyric Acid A Receptor Alpha 1 (gABRa1) | ELISA Kit Customized Service Offer |
Organism species: Mus musculus (Mouse)
CATALOG NO. | PRODUCT NAME | APPLICATIONS | |
Proteins | n/a | Recombinant Gamma-Aminobutyric Acid A Receptor Alpha 1 (gABRa1) | Recombinant Protein Customized Service Offer |
Antibodies | n/a | Monoclonal Antibody to Gamma-Aminobutyric Acid A Receptor Alpha 1 (gABRa1) | Monoclonal Antibody Customized Service Offer |
n/a | Polyclonal Antibody to Gamma-Aminobutyric Acid A Receptor Alpha 1 (gABRa1) | Polyclonal Antibody Customized Service Offer | |
Assay Kits | n/a | CLIA Kit for Gamma-Aminobutyric Acid A Receptor Alpha 1 (gABRa1) | CLIA Kit Customized Service Offer |
n/a | ELISA Kit for Gamma-Aminobutyric Acid A Receptor Alpha 1 (gABRa1) | ELISA Kit Customized Service Offer |
Organism species: Rattus norvegicus (Rat)
CATALOG NO. | PRODUCT NAME | APPLICATIONS | |
Proteins | n/a | Recombinant Gamma-Aminobutyric Acid A Receptor Alpha 1 (gABRa1) | Recombinant Protein Customized Service Offer |
Antibodies | n/a | Monoclonal Antibody to Gamma-Aminobutyric Acid A Receptor Alpha 1 (gABRa1) | Monoclonal Antibody Customized Service Offer |
n/a | Polyclonal Antibody to Gamma-Aminobutyric Acid A Receptor Alpha 1 (gABRa1) | Polyclonal Antibody Customized Service Offer | |
Assay Kits | n/a | CLIA Kit for Gamma-Aminobutyric Acid A Receptor Alpha 1 (gABRa1) | CLIA Kit Customized Service Offer |
n/a | ELISA Kit for Gamma-Aminobutyric Acid A Receptor Alpha 1 (gABRa1) | ELISA Kit Customized Service Offer |
- "Sequence and expression of human GABAA receptor alpha 1 and beta 1 subunits."FEBS Lett. 244:361-364(1989) [PubMed] [Europe PMC] [Abstract]
- "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)."Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract]
- "Isolation of a cDNA clone for the alpha subunit of the human GABA-A receptor."Biochem. Biophys. Res. Commun. 156:1039-1045(1988) [PubMed] [Europe PMC] [Abstract]
- "Novel alpha1 and gamma2 GABAA receptor subunit mutations in families with idiopathic generalized epilepsy."Eur. J. Neurosci. 34:237-249(2011) [PubMed] [Europe PMC] [Abstract]
- "GABRA1 and STXBP1: novel genetic causes of Dravet syndrome." Neurology 82:1245-1253(2014) [PubMed] [Europe PMC] [Abstract]
- "Mutation of GABRA1 in an autosomal dominant form of juvenile myoclonic epilepsy."Nat. Genet. 31:184-189(2002) [PubMed] [Europe PMC] [Abstract]
- "A mutation in the GABA(A) receptor alpha(1)-subunit is associated with absence epilepsy."Ann. Neurol. 59:983-987(2006) [PubMed] [Europe PMC] [Abstract]